{"result": "(\"entity\"<|>PANCREATITIS<|>EVENT<|>Pancreatitis is a severe inflammation of the pancreas that can lead to significant metabolic and nutritional challenges for patients.)\n##\n(\"entity\"<|>NUTRITIONAL SUPPORT<|>ORGANIZATION<|>Nutritional support refers to the medical practice of providing nutrition to patients who are unable to obtain adequate nutrition by mouth, often used in the context of managing conditions like pancreatitis.)\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic condition that affects how the body processes blood sugar (glucose), which can complicate the management of patients with pancreatitis.)\n##\n(\"entity\"<|>NE<|>ORGANIZATION<|>NE stands for Nutritional Enteral, a method of providing nutrition directly into the gastrointestinal tract.)\n##\n(\"entity\"<|>NP<|>ORGANIZATION<|>NP stands for Nutritional Parenteral, a method of providing nutrition intravenously, bypassing the gastrointestinal tract.)\n##\n(\"entity\"<|>RANSON CRITERIA<|>EVENT<|>Ranson criteria are a set of clinical criteria used to assess the severity of acute pancreatitis and predict outcomes.)\n##\n(\"entity\"<|>APACHE II<|>EVENT<|>APACHE II is a severity scoring system that evaluates the prognosis of critically ill patients, including those with acute pancreatitis.)\n##\n(\"relationship\"<|>PANCREATITIS<|>DIABETES<|>Pancreatitis can exacerbate diabetes symptoms due to metabolic stress and insulin resistance<|>7)\n##\n(\"relationship\"<|>PANCREATITIS<|>NUTRITIONAL SUPPORT<|>Nutritional support is critical in managing patients with pancreatitis to ensure they receive adequate nutrition<|>8)\n##\n(\"relationship\"<|>NE<|>PANCREATITIS<|>Nutritional Enteral (NE) is often initiated in patients with pancreatitis to provide necessary nutrition<|>9)\n##\n(\"relationship\"<|>NP<|>PANCREATITIS<|>Nutritional Parenteral (NP) is reserved for patients with pancreatitis who cannot tolerate enteral nutrition<|>8)\n##\n(\"relationship\"<|>RANSON CRITERIA<|>PANCREATITIS<|>Ranson criteria are used to assess the severity of pancreatitis and guide treatment decisions<|>6)\n##\n(\"relationship\"<|>APACHE II<|>PANCREATITIS<|>APACHE II scoring helps evaluate the prognosis of patients with acute pancreatitis<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: multidisciplinares de soporte nutricional16.\n\nInicio ingesta oral: En los casos leves, la autoselección de alimentos se ha asociado a una hospitalización más corta, con excelente respuesta clínica, no parece que iniciar una dieta baja en grasas tenga ninguna ventaja frente a una dieta oral líquida28,29. En cuanto al momento concreto de inicio no hay nada claro, los clínicos tienen en cuenta la ausencia de dolor, la gravedad de la pancreatitis, los marcadores bioquímicos y la mejora radiológica por TC.\n\nNP: En algunos pacientes la NE no es posible o no cubre todos los requerimientos necesarios, siendo preciso utilizar NP. Algunos pacientes presentan una importante exacerbación de los síntomas de pancreatitis al inicio de NE a pesar de una correcta colocación de la sonda y de utilizar fórmulas elementales. Si la causa de la pancreatitis no ha sido la hipertrigliceridemia, las emulsiones intravenosas de lípidos no aumentan los síntomas. Podríamos reiniciar la emulsión lipídica con seguridad cuando la concentración de triglicéridos es menor de 400 mg/dl. Es fundamental mantener el aporte de lípidos en <1g/kg y realizar un estricto control glucémico. Cuando la dislipemia se produce en el contexto de una pancreatitis, suele estar relacionada con hiperglucemia o dislipemia familiar30.\n\nEn nuestro caso el paciente tenía indicado inicio de NE a las 48h del ingreso, dado que presentaba criterios de gravedad de la pancreatitis. Sin embargo, desde cirugía se inició NP a las 24 horas del ingreso, en el pico máximo de inflamación. En un ensayo aleatorio prospectivo, el aporte de NP precoz fue causa de daño neto comparado con tratamiento estándar17. Dado que la colocación de sonda yeyunal se realizó vía endoscópica, se demoró hasta varios días después del ingreso. El paciente presentó una importante descompensación hiperglucémica de su diabetes además de una infección de catéter que posiblemente no hubiesen sucedido si se hubiese iniciado NE en lugar de NP. Al pasar a NE, la cual toleró perfectamente, mejoró su control glucémico pero seguía presentando mal control y altos requerimientos de insulina por lo que se optó por una fórmula específica para diabetes que facilitó su manejo. A pesar de todo, el paciente pudo prescindir de la insulina como parte del tratamiento de su diabetes a las pocas semanas del alta hospitalaria.\n---\n# Conclusiones\n\nLa pancreatitis aguda severa asocia un hipermetabolismo similar a la sepsis, catabolismo desproporcionado, respuesta inflamatoria sistémica y rápido deterioro del estado nutricional.\n\nEstá indicado iniciar NE a las 48-72h del ingreso en aquellos con al menos tres criterios Ranson o una puntuación APACHE II >10.\n\nInicialmente debe colocarse una sonda nasoyeyunal y comenzar con una solución polimérica estándar. Cuando existe DM asociada las fórmulas específicas pueden favorecer la optimización del control glucémico.\n\nLa NP se reserva para los que no toleran NE o no es viable, debiendo esperar hasta el 5º día o cuando haya pasado el pico máximo de inflamación para evitar morbilidad³¹.\n---\n# Bibliografía\n\n1. Norman JG. New approaches to acute pancreatitis: role of inflammatory mediators. Digestion. 1999;60(suppl 1):57-60.\n\n2. Khan AS, Latif SU, Eloubeidi MA. Controversies in the etiologies of acute pancreatitis. JOP. 2010;11(6):545-552.\n\n3. Tonsi AF, Bacchion M, Crippa S, Malleo G, Bassi C. Acute pancreatitis at the beginning of the 21st century: the state of the art. World J Gastroenterol. 2009; 15(24): 2945-2959.\n\n4. Whitcomb DC. Clinical practice. Acute pancreatitis. N Engl J Med. 2006; 354(20):2142-2150.\n\n5. Sax HC, Warner BW, Talamini MA, et al. Early total parenteral nutrition in acute pancreatitis: lack of beneficial effects. Am J Surg. 1987;153:117-124.\n\n6. Di Carlo V, Nespoli A, Chiesa R, et al. Hemodynamic and metabolic impairment in acute pancreatitis. World J Surg. 1981; 5:329-339.\n\n7. Shaw JH, Wolfe RR. Glucose, fatty acid, and urea kinetics in patients with severe pancreatitis. Ann Surg.1986; 204: 665-672.\n\n8. Dickerson RN, Vehe KL, Mullen JL, Feurer ID. Resting energy expenditure in patients with pancreatitis. Crit Care Med. 1991; 19: 484-490.\n\n9. Marulendra S, Kirby D. Nutrition support in pancreatitis. Nutr Clin Pract. 1995;10:45-53.\n\n10. Havala T, Shronts\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}